Exchange: NASDAQ·Updated 07:34 PM EDT
ORKA logo

ORKAOruka Therapeutics Inc.

$95.00
$2.61
(2.85%)
Today
Closed $94.32
$0.68
(0.72%)
After Hours
EarningsAug 10
Mkt Cap$5.53B
Vol585,505.00
News
all
press releases
Oruka Therapeutics Shares Drop After Hours After Fairmount Unloads 3.55 Million Shares
Oruka Therapeutics stock falls after hours after Fairmount sells a $300 million stake via SEC filing.read more...
Benzinga
More News
Oruka Stock Is Now Up Nearly 700%. Here's What a $687,000 Insider Sale Could Mean
Key PointsAn Oruka Therapeutics executive reported selling 9,854 directly held Common Stock shares for a total value of $687K based on a weighted average price of $69.72 per share as of June 15, 2026...
Nasdaq News: Markets
Oruka Therapeutics' Head of Finance Sold Over 10,000 Company Shares. What Does That Mean for Investors?
Key PointsArjun Agarwal sold 10,290 shares for a transaction value of approximately ~$608,000, based on a weighted average price of $59.07 per share on May 18, 2026...
Nasdaq News: Markets
Monday Sector Leaders: Biotechnology, Shipping Stocks
In trading on Monday, biotechnology shares were relative leaders, up on the day by about 2.5%. Leading the group were shares of Apogee Therapeutics, up about 46.8% and shares of Oruka Therapeutics up about 18.1% on the day. Also showing relative strength are shipping shares, u...
Nasdaq News: Markets
Oruka Therapeutics, Inc. (ORKA) Upgraded to Buy: What Does It Mean for the Stock?
Oruka Therapeutics, Inc. (ORKA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
Wall Street Analysts Believe Oruka Therapeutics, Inc. (ORKA) Could Rally 111.13%: Here's is How to Trade
The mean of analysts' price targets for Oruka Therapeutics, Inc. (ORKA) points to an 111.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks
An Oruka Therapeutics (ORKA) Insider Sold 105,000 Shares Worth $6.2 Million
An Oruka Therapeutics (ORKA) Insider Sold 105,000 Shares Worth $6.2 Million...
Yahoo! Finance: News
Upcoming Phase 2 Readouts Could Redefine These Biotech Stocks
Upcoming Phase 2 Readouts Could Redefine These Biotech Stocks $NTHI, $ORKA, $ABVX, $CGEM, $SYRE, $APGE
24-7 Market News
Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA)
Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA...
Yahoo! Finance: News
Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon Technology
Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon Technology Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.